Breast Cancer Market

Breast Cancer Market is valued at USD 22.55 Billion in 2020 and expected to reach USD 45.94 Billion by 2027 with the CAGR of 10.70% over the forecast period.

Breast Cancer Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027.  Rising incidence of breast cancer, increasing female geriatric population and growing governmental initiatives for new therapies are some major factors driving the growth of the global breast cancer market.  

Scope oof the Breast Cancer Market Report:

Brest cancer is type of cancer that forms in tissues of the breast. It is the most commonly occurring cancer in women and the second most common cancer among others. Some of the common symptoms of the breast cancer are formation of lump in a breast, red patches on the skin. The most common type of breast cancer is ductal carcinoma, which begins in the lining of the milk ducts; another type of breast cancer is lobular carcinoma, which begins in the lobules of the breast. In addition, invasive breast cancer is breast cancer that has spread from where it began in the breast ducts or lobules to surrounding normal tissue. Breast cancer found in both men and women, although male breast cancer is rare.

Breast cancer market report is segmented on the basis of type, treatment, end user and by regional & country level. Based upon type, breast cancer market is classified into invasive ductal carcinoma, invasive lobular carcinoma and other. Based upon treatment, breast cancer market is classified into chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy and hormone therapy. Based upon end user, breast cancer market is classified into hospital pharmacies, private pharmacies and others.

The regions covered in this breast cancer market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of breast cancer is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players Breast Cancer-

Breast cancer market report covers prominent players are Oncothyreon Inc ,Astellas , Bipar Sciences , Pfizer , Novartis AG , Oncogenex ,Apthera Inc , BioNumerik Pharmaceuticals ,Puma Biotechnology , Bristol-Myers Squibb company , Actavis, Inc. , Hospira, Sanofi S.A. , Eli Lilly and Company , AstraZeneca ,F. Hoffmann-La Roche , GlaxoSmithKline , Genentech , Teva Pharmaceutical Industries ,Sun Pharmaceutical Industries Ltd ,Accord Healthcare, Inc. ,Gilead Sciences, Inc. , Bayer AG  and Others.

Click Here to know more about Companies

Sun Pharma Launched Ready-to-Infuse INFUGEM in the U.S.

 News: April 08, 2019, Sun Pharmaceutical Industries Ltd. launched INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use in the U.S. INFUGEM, was approved by the U.S. Food and Drug Administration (FDA) in July 2018 in combination with other drugs for the treatment of breast, ovarian, non-small cell lung cancers, and as a single agent for the treatment of pancreatic cancer. It is the first chemotherapy product that comes in a premixed, ready-to-infuse formulation.

Breast Cancer Market Dynamics –

Rising incidence of breast cancer, increasing female geriatric population and growing governmental initiatives for new therapies are some major factors driving the growth of the global breast cancer market. According to American Cancer Society, In the US, there was an estimated 266,120 new cases of invasive breast cancer diagnosed in women and 2,550 cases diagnosed in men in 2018 According to the American Heart Association, about 2,200 Americans die of disorder every day, a mean of 1 death every 40 seconds.  Furthermore, growing obesity, lack of physical exercise, overexposure to radiation and drinking alcohol are also contributed in the growth of the market. Moreover, due to the advancement in cancer research, more patients with cancer are being successfully treated will propel growth of markets.  According to WHO, The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. However, High capital investment, expensive medications, long approval time for the drugs and lack of awareness in several countries will hamper the development of breast cancer market. However, technological advancement with effective cancer treatment and the increasing investment in cancer research is expected to boost the opportunity for the growth of breast cancer market in forcaste peried.

  Report Coverage

Key Benefits for Breast Cancer Market Reports –

• Global Market report covers in depth historical and forecast analysis.
• Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Market report helps to identify opportunities in market place.
• Global Market report covers extensive analysis of emerging trends and competitive landscape.

Breast Cancer Market Segmentation –

By Type:-

• Invasive Ductal Carcinoma
• Invasive Lobular Carcinoma
• Others

By Treatment:-

• Chemotherapy
• Surgery & Radiation Therapy
• Targeted Therapy
• Biologic Therapy
• Hormone Therapy

By End-User:-

• Hospital Pharmacies
• Private Pharmacies
• Others

Breast Cancer Market Regional Analysis –

North America is dominating the breast cancer market with the highest share due to rising awareness among the people about advanced treatment for cancer, presence of leading players, established healthcare infrastructure and availability of branded drugs, changing lifestyle and increasing prevalence of breast cancer are a number of the factors liable for its large share. Besides, favorable government initiatives and increase in number of research collaborations are some of the drivers expected to accelerate the regional market growth. According to CDC, Breast cancer is the second most common cancer among women in the United States.  As per research report, 42,170 women in the U.S. are expected to die due to breast cancer in 2020.

The Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period with due to the increase in healthcare expenditure, growing  geriatric population rate, growing prevalence of breast cancer, rising awareness about early diagnosis, developing healthcare infrastructure, and availability of effective treatment in emerging countries, such as China and India. In the Asia-Pacific region, rising disposable income, adoption of western lifestyle, living more sedentary lives and consuming junk foods with higher energy and fat. According to Organisation for Economic Co-operation and Development (OECD), in high income Asia-Pacific countries, the share of population aged over 65 years is expected to double to reach and on average 27.6% in 2050.

By Regional & Country Analysis:-

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Frequently Asked Questions (FAQ) :